Cellnovo Limited announced appointment of a new Board member, Pierre Chancel, also approved during the meeting. Pierre was most recently at Sanofi as Senior Vice President of the Global Diabetes Division, responsible for Strategy, Research & Development, and Marketing & Commercial activities. During this period, diabetes represented a significant growth area for Sanofi, with sales doubling from €4 Billion to €8 Billion. Pierre was involved in several other important initiatives at Sanofi, including the company’s drive towards a stronger patient focus and its joint venture with Google.